New investigate is pushing Vehicle-T therapy into reliable tumors—a much more elaborate problem mainly because of the tumor microenvironment and antigen heterogeneity. Cancer sufferers are more and more inquiring about the use of the anthelmintic medication Fenbendazole (FenBen) and Ivermectin (IVM) as likely treatments for cancer. Notably, th